High blood pressure is often treated like a universal condition. But for many women, hypertension does not always look, feel, or behave the way medicine has traditionally expected it to.
In clinics, women frequently describe symptoms such as headaches, palpitations, dizziness, fatigue, poor sleep, and a persistent feeling that something is not right. Many also struggle with medication side effects including cramps, coughing, electrolyte imbalance, and feeling constantly light-headed. Yet these concerns are often brushed aside as anxiety, stress, or poor compliance with treatment.
For years, cardiovascular research and treatment models have largely been built around male symptoms and patterns. This has created what experts have long referred to as the 'Yentl syndrome', where women’s symptoms are taken seriously only when they resemble men’s experiences.
But hypertension in women follows a different path.
As women age, they are more likely to develop higher systolic blood pressure, increased arterial stiffness, and greater pressure on the heart and brain. This helps explain why women with hypertension are more vulnerable to stroke, atrial fibrillation, heart failure with preserved ejection fraction, vascular cognitive decline, and other forms of cardiovascular disease that may not present as the 'classic' heart attack symptoms often associated with men.
The condition is also deeply shaped by social and lifestyle realities.
Across many parts of South Asia, women often have fewer opportunities for physical activity, while carrying a higher burden of unpaid caregiving, emotional labour, financial stress, and restricted autonomy. These factors contribute significantly to chronic stress, obesity, metabolic syndrome, and rising blood pressure over time.
Perhaps the most overlooked aspect of women’s hypertension, however, is pregnancy.
Conditions such as pre-eclampsia and eclampsia remain major causes of maternal illness and death worldwide. In many regions, delayed diagnosis, inconsistent antenatal care, and limited access to treatment continue to put both mothers and babies at risk. More importantly, pregnancy-related hypertension should not be viewed as a temporary complication that disappears after childbirth. It is often an early warning sign for future chronic hypertension and long-term cardiovascular disease.
Awareness campaigns around women’s heart health have grown in recent years, but experts argue that awareness alone is no longer enough.
Women’s hypertension care needs to move beyond one-size-fits-all treatment. It requires listening more carefully to women’s lived experiences, understanding the impact of pregnancy on long-term health, and recognising the unique biological and social realities that shape cardiovascular risk in women.
Because, better care does not mean special treatment. It means treatment that finally reflects women’s realities.